Endothelial and erectile dysfunction, diabetes mellitus, and the metabolic syndrome: Common pathways and treatments?

American Journal of Cardiology

Volumn 96, Issue 12 SUPPL. 2, 2005, Pages 13-18

  Fonseca, Vivian ^a,b   Jawa, Ali ^a  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FOLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN SENSITIZING AGENT; NICOTINIC ACID; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

AUTONOMIC NEUROPATHY; CLINICAL TRIAL; COMORBIDITY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDUCED HEADACHE; DYSPEPSIA; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; GLYCEMIC CONTROL; HUMAN; INSULIN RESISTANCE; META ANALYSIS; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

EID: 29544435525     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.07.005     Document Type: Article

References (45)

1. J.H. Romeo, A.D. Seftel, Z.T. Madhun, D.C. Aron Sexual function in men with diabetes type 2 association with glycemic control J Urol 163 2000 788 791
2. D.K. McCulloch, I.W. Campbell, F.C. Wu, R.J. Prescott, B.F. Clarke The prevalence of diabetic impotence Diabetologia 18 1980 279 283
3. H.A. Feldman, I. Goldstein, D.G. Hatzichristou, R.J. Krane, J.B. McKinlay Impotence and its medical and psychosocial correlates results of the Massachusetts Male Aging Study J Urol 151 1994 54 61
4. F.E. Kaiser Erectile dysfunction in the aging man Med Clin North Am 83 1999 1267 1278
5. R. Klein, B.E. Klein, K.E. Lee, S.E. Moss, K.J. Cruickshanks Prevalence of self-reported erectile dysfunction in people with long-term IDDM Diabetes Care 19 1996 135 141
6. G.M. Reaven Banting lecture 1988 role of insulin resistance in human disease Diabetes 37 1988 1595 1607
7. S.I. McFarlane, M. Banerji, J.R. Sowers Insulin resistance and cardiovascular disease J Clin Endocrinol Metab 86 2001 713 718
8. M. Pyorala, H. Miettinen, P. Halonen, M. Laakso, K. Pyorala Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men the 22-year follow-up results of the Helsinki Policemen Study Arterioscler Thromb Vasc Biol 20 2000 538 544
9. V.A. Fonseca Risk factors for coronary heart disease in diabetes Ann Intern Med 133 2000 154 156
10. V. Fonseca, C. Desouza, S. Asnani, I. Jialal Nontraditional risk factors for cardiovascular disease in diabetes Endocr Rev 25 2004 153 175
11. M.P. Stern Diabetes and cardiovascular disease the "common soil" hypothesis Diabetes 44 1995 369 374
12. C.G. Bacon, M.A. Mittleman, I. Kawachi, E. Giovannucci, D.B. Glasser, E.B. Rimm Sexual function in men older than 50 years of age results from the health professionals follow-up study Ann Intern Med 139 2003 161 168
13. M.K. Walczak, N. Lokhandwala, M.B. Hodge, A.T. Guay Prevalence of cardiovascular risk factors in erectile dysfunction J Gend Specif Med 5 2002 19 24
14. W.S. Chung, J.H. Sohn, Y.Y. Park Is obesity an underlying factor in erectile dysfunction? Eur Urol 36 1999 68 70
15. P. Ziccardi, F. Nappo, G. Giugliano, K. Esposito, R. Marfella, M. Cioffi, F. D'Andrea, A.M. Molinari, D. Giugliano Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year Circulation 105 2002 804 809
16. D. Richardson, A. Vinik Etiology and treatment of erectile failure in diabetes mellitus Curr Diab Rep 2 2002 501 509
17. D.B. Jiaan, A.D. Seftel, J. Fogarty, N. Hampel, W. Cruz, J. Pomerantz, M. Zuik, V.M. Monnier Age-related increase in an advanced glycation end product in penile tissue World J Urol 13 1995 369 375
18. M.J. Jevtich, M. Edson, W.D. Jarman, H.H. Herrera Vascular factor in erectile failure among diabetics Urology 19 1982 163 168
19. T. Burchardt, M. Burchardt, J. Karden, R. Buttyan, A. Shabsigh, A. de la Taille, P.Y. Ng, A.G. Anastasiadis, R. Shabsigh Reduction of endothelial and smooth muscle density in the corpora cavernosa of the streptozotocin induced diabetic rat J Urol 164 2000 1807 1811
20. A.D. Seftel, N.D. Vaziri, Z. Ni, K. Razmjouei, J. Fogarty, N. Hampel, J. Polak, R.Z. Wang, K. Ferguson, C. Block, C. Haas Advanced glycation end products in human penis elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS Urology 50 1997 1016 1026
21. B.L. Bemelmans, E.J. Meuleman, W.H. Doesburg, S.L. Notermans, F.M. Debruyne Erectile dysfunction in diabetic men the neurological factor revisited J Urol 151 1994 884 889
22. D. Vernet, L. Cai, H. Garban, M.L. Babbitt, F.T. Murray, J. Rajfer, N.F. Gonzalez-Cadavid Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction Endocrinology 136 1995 5709 5717
23. R.F. Spark, R.A. White, P.B. Connolly Impotence is not always psychogenic newer insights into hypothalamic-pituitary-gonadal dysfunction JAMA 243 1980 750 755
24. R.S. Tan, S.J. Pu Impact of obesity on hypogonadism in the andropause Int J Androl 25 2002 195 201
25. J.J. Cartledge, I. Eardley, J.F. Morrison Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin BJU Int 85 2000 735 741
26. F.J. Wackers, L.H. Young, S.E. Inzucchi, D.A. Chyun, J.A. Davey, E.J. Barrett, R. Taillefer, S.D. Wittlin, G.V. Heller, N. Filipchuk Detection of silent myocardial ischemia in asymptomatic diabetic subjects the DIAD study Diabetes Care 27 2004 1954 1961
27. J. Calles-Escandon, M. Cipolla Diabetes and endothelial dysfunction a clinical perspective Endocr Rev 22 2001 36 52
28. A.E. Caballero, S. Arora, R. Saouaf, S.C. Lim, P. Smakowski, J.Y. Park, G.L. King, F.W. LoGerfo, E.S. Horton, A. Veves Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes Diabetes 48 1999 1856 1862
29. R. Ross Atherosclerosis an inflammatory disease N Engl J Med 340 1999 115 126
30. K.L. Billups, D.R. Kaiser, A.S. Kelly, R.A. Wetterling, M.Y. Tsai, N. Hanson, A.J. Bank Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction Int J Impot Res 15 2003 231 236
31. L. De Angelis, M.A. Marfella, M. Siniscalchi, L. Marino, F. Nappo, F. Giugliano, D. De Lucia, D. Giugliano Erectile and endothelial dysfunction in type II diabetes a possible link Diabetologia 44 2001 1155 1160
32. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, D.M. Nathan Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 2002 393 403
33. K. Esposito, C. Di Palo, R. Marfella, D. Giugliano The effect of weight loss on endothelial functions in obesity response to Sciacqua et al Diabetes Care 26 2003 2968 2969
34. K. Esposito, A. Pontillo, C. Di Palo, G. Giugliano, M. Masella, R. Marfella, D. Giugliano Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women a randomized trial JAMA 289 2003 1799 1804
35. K. Esposito, F. Giugliano, C. Di Palo, G. Giugliano, R. Marfella, F. D'Andrea, M. D'Armiento, D. Giugliano Effect of lifestyle changes on erectile dysfunction in obese men a randomized controlled trial JAMA 291 2004 2978 2984
36. O. Hamdy, S. Ledbury, C. Mullooly, C. Jarema, S. Porter, K. Ovalle, A. Moussa, A. Caselli, A.E. Caballero, P.A. Economides, A. Veves, E.S. Horton Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome Diabetes Care 26 2003 2119 2125
37. H.A. Fink, D.R. Mac, I.R. Rutks, D.B. Nelson, T.J. Wilt Sildenafil for male erectile dysfunction a systematic review and meta-analysis Arch Intern Med 162 2002 1349 1360
38. C.C. Carson, A.L. Burnett, L.A. Levine, A. Nehra The efficacy of sildenafil citrate (Viagra) in clinical populations an update Urology 60 suppl 2 2002 12 27
39. G.B. Brock, C.G. McMahon, K.K. Chen, T. Costigan, W. Shen, V. Watkins, G. Anglin, S. Whitaker Efficacy and safety of tadalafil for the treatment of erectile dysfunction results of integrated analyses J Urol 168 2002 1332 1336
40. I. Saenz de Tejada, G. Anglin, J.R. Knight, J.T. Emmick Effects of tadalafil on erectile dysfunction in men with diabetes Diabetes Care 25 2002 2159 2164
41. H. Porst, R. Rosen, H. Padma-Nathan, I. Goldstein, F. Giuliano, E. Ulbrich, T. Bandel The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction the first at-home clinical trial Int J Impot Res 13 2001 192 199
42. C. Desouza, A. Parulkar, D. Lumpkin, D. Akers, V.A. Fonseca Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes Diabetes Care 25 2002 1336 1339
43. S.D. Katz, K. Balidemaj, S. Homma, H. Wu, J. Wang, S. Maybaum Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure J Am Coll Cardiol 36 2000 845 851
44. J.P. Halcox, K.R. Nour, G. Zalos, R.A. Mincemoyer, M. Waclawiw, C.E. Rivera, G. Willie, S. Ellahham, A.A. Quyyumi The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia J Am Coll Cardiol 40 2002 1232 1240
45. C.A. Derby, B.A. Mohr, I. Goldstein, H.A. Feldman, C.B. Johannes, J.B. McKinlay Modifiable risk factors and erectile dysfunction can lifestyle changes modify risk? Urology 56 2000 302 306